ATXI:Avenue Therapeutics Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$6.20 NASDAQ 7:31a ET
April 24 '24 		Avenue Therapeutics Announces Reverse Stock Split GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Avenue Therapeutics Announces Reverse Stock Split
     GlobeNewswire
    Full Story →

    Headline News
    Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
    8:30a ET March 25 '24 GlobeNewswire
    Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
    4:05p ET March 18 '24 GlobeNewswire
    Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
    8:16a ET March 15 '24 GlobeNewswire
    More News →
    Day  29.34%Week  36.41%Month  45.83%More Charting →
    April 26 '24. Markets Closed.
    Last $6.20
    Day change   29.34%$2.58
    Open $7.48
    Gap at open $1.30
    Previous close $8.78
    Trading volume 235,142
    10 Day avg vol. 38,864
    Shares out. 590.0K
    Market cap. $3.7Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 25 '24.

    Historical Price Performance
    3 month   44.89% 
    6 month   78.25% 
    1 year   91.30% 
    2 year   98.51% 

    Earnings
    Previous 12m -$1.78
    Next 12m Estimate -$30.75
    P/E ratio 3.5x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.